6 studies found for:    9749478 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer
Conditions: Secondary Malignant Neoplasm of Lymph Node;   Prostatic Neoplasms
Interventions: Procedure: Radical Prostatectomy;   Procedure: Extended Lymphadenectomy
2 Active, not recruiting Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: < 15% risk of + LN;   Radiation: > 15% risk of + LN
3 Recruiting High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer;   Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer
Interventions: Radiation: Brachytherapy;   Radiation: Stereotactic Body Radiation Therapy;   Procedure: Quality-of-life assessment;   Other: Questionnaire administration
4 Active, not recruiting
Has Results
Proton Therapy for Low and Intermediate Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: Low Risk Proton Radiation;   Radiation: Intermediate Risk Proton Radiation
5 Recruiting Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: 70 Gy/CGE;   Radiation: 72.5 Gy/CGE
6 Recruiting Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: Alisertib;   Drug: Abiraterone acetate;   Drug: Prednisone

Indicates status has not been verified in more than two years